Essential Partners
MRNA icon

Essential Partners’s Moderna MRNA Stock Holding History

Essential Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$24.1K Hold
125
– – 0.01% 849
2026
Q2 		$8.75K Buy
+125
New +$6.47K ﹤0.01% 1274
2025
Q4 		– Sell
-3
Closed -$77 – 2868
2025
Q3 		$77 Buy
+3
New +$84 ﹤0.01% 2521

Other funds holding MRNA

Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures, LLc
Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
LAI
Legal Advantage Investments Los Altos Hills, California $468M AUM 7.83% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Essential Partners's MRNA Position: Q3 2026 in Review

Essential Partners held its Moderna (MRNA) position steady in Q3 2026 at 125 shares worth $24.1K. The position accounts for 0.01% of the portfolio, ranked #849.

Essential Partners first reported a position in MRNA in Q3 2025 and has held it in 3 quarters since. 221 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Essential Partners held 125 shares of Moderna worth $24.1K as of Q3 2026.
  • Essential Partners left its Moderna share count unchanged in Q3 2026.
  • Moderna made up 0.01% of Essential Partners's portfolio in Q3 2026, its #849 holding.
  • Essential Partners first reported a position in Moderna in Q3 2025 and has held it in 3 quarters since.
  • 221 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.